Home
Glenmark Pharmaceuticals Ltd Board of Directors
Board of Directors at Glenmark Pharmaceuticals Ltd
Non Executive Director
Executive Director (Corporate)
Independent Non Exe. Director
Chairman & Managing Director
Independent Non Exe. Director
Key Highlights
- Glenn Saldanha joins the board as Chairman & Managing Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Cheryl Pinto continues to serve as the Executive Director (Corporate) in 2024, maintaining the same position as in the previous year.
- V S Mani continues to serve as the Executive Director & Group CFO in 2024, maintaining the same position as in the previous year.
- B E Saldanha continues to serve as the Non Executive Director in 2024, maintaining the same position as in the previous year.
- Rajesh Desai. continues to serve as the Independent Non Exe. Director in 2024, maintaining the same position as in the previous year.

Glenmark Pharmaceuticals Ltd
NSE: GLENMARK
Share Price
Last Ten Days Market Price
Date | |
---|---|
04 Apr 2025 | 1499.15 |
03 Apr 2025 | 1542.9 |
02 Apr 2025 | 1516.3 |
01 Apr 2025 | 1508.75 |
28 Mar 2025 | 1540.05 |
27 Mar 2025 | 1520.75 |
26 Mar 2025 | 1464.1 |
25 Mar 2025 | 1480.2 |
24 Mar 2025 | 1493.1 |
21 Mar 2025 | 1511.45 |
Company Fundamentals for Glenmark Pharmaceuticals Ltd
Market Cap
42,304 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
5.0
Day’s High
1542.95
Day’s Low
1469.45
DTE
0.2
ROE
-23.5
52 Week High
1830.05
52 Week Low
978.9
ROCE
17.3
Market Price of Glenmark Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Glenmark Pharmaceuticals Ltd News Hub
Glenmark Pharmaceuticals Ltd spurts 2.5%, rises for fifth straight session
Glenmark Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 1
Read more
21 Aug 24
Glenmark Pharmaceuticals Ltd soars 4.33%, rises for third straight session
Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 163
Read more
19 Aug 24
Glenmark Pharma gains after American subsidiary launches Olopatadine generic
The solution is the generic version of 'Pataday Twice Daily Relief', which is distributed by Alcon L
Read more
19 Aug 24
Glenmark launches Olopatadine Hydrochloride Ophthalmic Solution
Glenmark Therapeutics Inc., USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalmic Solutio
Read more
19 Aug 24